Home > Boards > US Listed > Biotechs > ImmunoGen, Inc. (IMGN)

News: $IMGN ImmunoGen Announces Accelerated Approval Pathway for

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
whytestocks Member Profile
 
Followed By 57
Posts 7,611
Boards Moderated 0
Alias Born 06/04/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 3:56:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 7:52:15 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 7:51:47 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/11/2020 4:03:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:39:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:39:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:38:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:38:05 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2020 8:37:34 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/14/2020 5:20:14 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:54:02 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 12:40:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/14/2020 6:38:07 AM
ImmunoGen Reports Recent Progress and 2019 Financial Results Business Wire - 2/14/2020 6:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 2:59:40 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2020 3:04:36 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 7:53:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:28:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:28:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:27:09 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:26:34 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:25:29 AM
Schedule 13g Edgar (US Regulatory) - 2/10/2020 9:11:28 AM
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences Business Wire - 2/6/2020 4:30:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 11:50:20 AM
whytestocks   Tuesday, 12/17/19 07:00:18 AM
Re: None
Post # of 668 
News: $IMGN ImmunoGen Announces Accelerated Approval Pathway for Mirvetuximab Soravtansine in Ovarian Cancer

Top-Line Data from New Pivotal Single-Arm Trial, SORAYA, Expected in First Half of 2021 Confirmatory MIRASOL Trial for Mirvetuximab on Track to Start by Year-End Conference Call to be Held at 8:00 a.m. ET Today ImmunoGen Inc. , (Nasdaq: IMGN), a leader in the expanding fie...

Read the whole news IMGN - ImmunoGen Announces Accelerated Approval Pathway for Mirvetuximab Soravtansine in Ovarian Cancer

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist